SCLERODERMA CLINICAL TRIALS
Data sourced from IRS 990 public filings
SCLERODERMA CLINICAL TRIALS TO FOSTER SCIENTIFIC RESEARCH AND TO ADVANCE MEDICAL RESEARCH IN THE FORM OF TREATMENT TRIALS IN SCLERODERMA ON A WORLDWIDE BASIS.
International
Research & Evaluation
General Population
Medical Research
Health
Annual Revenue
$326,433
Known Funders
0
Grants Received
0
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $326,433 | $298,602 | $4,030,611 |
| 2023 | $264,484 | $210,242 | $3,466,894 |
| 2022 | $271,981 | $177,441 | $2,536,410 |
| 2021 | $197,214 | $95,927 | $2,441,870 |
| 2020 | $222,811 | $168,700 | $2,340,583 |
| 2019 | $1,210,041 | $126,858 | $2,286,472 |
| 2018 | $1,187,078 | $76,552 | $1,203,289 |
Top Funders
No funder data available yet for this nonprofit.
Key Personnel
From 2024 IRS 990 filing
R
ROBYN THERESE DOMSIC-DEGAZIO
PRESIDENT
Officer
T
TRACY FRENCH
VICE PRESIDE
Officer
J
JERRY A MOLITOR
TREASURER
Officer
V
VANESSA SMITH
SECRETARY
Officer
Frequently Asked Questions
Other Nonprofits in Massachusetts
MASS GENERAL BRIGHAM INCORPORATED &$23,474,745,033
FIDELITY INVESTMENTS CHARITABLE GIFT FUND$18,558,596,882
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS HMO BLUE INC$5,928,518,480
Massachusetts Institute of Technology$5,855,286,000
BOSTON MEDICAL CENTER HEALTH PLAN INC$5,196,975,117
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.